Siren »

Blueprint Medicines shares owned by Siren

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Siren from 13F filings

Historical chart of Siren investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Siren

Quarter filed Position value Share count Share price at filing
2025-03-31 $64M 726k 88.51

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Disc Medicine (IRON)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Avidity Biosciences Ord (RNA)
Stoke Therapeutics (STOK)
Lexicon Pharmaceuticals Com New (LXRX)
Rhythm Pharmaceuticals (RYTM)

View all positions for Siren

Top funds holding Blueprint Medicines

DekaBank Deutsche Girozentrale
Van Eck Associates Corp.
IFP Advisors
Advisor Group Holdings
Huntington National Bank

View all funds holding Blueprint Medicines